ACB (Aurora Cannabis) Cyclically Adjusted Revenue per Share: $11.07 (As of Mar. 2026)


ACB Aurora Cannabis Inc ACB
59 GF Score
Price $2.86
GF Value $4.15
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Aurora Cannabis Cyclically Adjusted Revenue per Share?

Aurora Cannabis ACB +1.07% 59 Cyclically Adjusted Revenue per Share is $11.07 as of Mar. 2026. GuruFocus rates ACB with a GF Score™ of 59/100 and a GF Value™ of $4.15 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Aurora Cannabis's adjusted revenue per share for the three months ended in Mar. 2026 was $0.482. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $11.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Aurora Cannabis's average Cyclically Adjusted Revenue Growth Rate was -1.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -5.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Aurora Cannabis was 49.80% per year. The lowest was -5.70% per year. And the median was 1.40% per year.

As of today (2026-07-04), Aurora Cannabis's current stock price is $2.8589. Aurora Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $11.07. Aurora Cannabis's Cyclically Adjusted PS Ratio of today is 0.26.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aurora Cannabis was 230.43. The lowest was 0.25. And the median was 3.96.


Aurora Cannabis  (NAS:ACB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Aurora Cannabis's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.8589/11.07
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aurora Cannabis was 230.43. The lowest was 0.25. And the median was 3.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Aurora Cannabis Cyclically Adjusted Revenue per Share Related Terms


Aurora Cannabis Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Aurora Cannabis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Cannabis Cyclically Adjusted Revenue per Share Chart

Aurora Cannabis Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.78 14.35 12.35 11.01 11.07

Aurora Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.01 11.52 11.09 11.15 11.07

ACB vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurora Cannabis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aurora Cannabis's Cyclically Adjusted PS Ratio falls into.


ACB
59GF Score
Aurora Cannabis Inc ACB
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Cannabis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aurora Cannabis's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.482/132.2600*132.2600
=0.482

Current CPI (Mar. 2026) = 132.2600.

Aurora Cannabis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.838 102.002 1.087
201609 1.531 101.765 1.990
201612 1.324 101.449 1.726
201703 1.482 102.634 1.910
201706 1.502 103.029 1.928
201709 2.143 103.345 2.743
201712 2.790 103.345 3.571
201803 3.119 105.004 3.929
201806 2.899 105.557 3.632
201809 3.166 105.636 3.964
201812 4.994 105.399 6.267
201903 5.826 106.979 7.203
201906 8.593 107.690 10.554
201909 6.426 107.611 7.898
201912 4.615 107.769 5.664
202003 5.275 107.927 6.464
202006 4.393 108.401 5.360
202009 4.349 108.164 5.318
202012 3.145 108.559 3.832
202103 2.264 110.298 2.715
202106 2.268 111.720 2.685
202109 2.395 112.905 2.806
202112 2.388 113.774 2.776
202203 1.856 117.646 2.087
202206 1.575 120.806 1.724
202209 1.229 120.648 1.347
202212 1.391 120.964 1.521
202303 1.421 122.702 1.532
202306 1.591 124.203 1.694
202309 1.172 125.230 1.238
202312 1.012 125.072 1.070
202403 0.963 126.258 1.009
202406 1.172 127.522 1.216
202409 1.063 127.285 1.105
202412 1.110 127.364 1.153
202503 0.456 129.181 0.467
202506 1.275 129.892 1.298
202509 1.143 130.290 1.160
202512 1.191 130.370 1.208
202603 0.482 132.260 0.482

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $11.07 mean?
Aurora Cannabis (ACB) has a Cyclically Adjusted Revenue per Share of $11.07 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aurora Cannabis and its competitors.
Is Aurora Cannabis' Cyclically Adjusted Revenue per Share too high?
Aurora Cannabis' current Cyclically Adjusted Revenue per Share is $11.07. Overall, Aurora Cannabis has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Aurora Cannabis' Cyclically Adjusted Revenue per Share of $11.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aurora Cannabis and its competitors. Aurora Cannabis's current Cyclically Adjusted Revenue per Share is $11.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (ACB) is currently considered Possible Value Trap. The stock's GF Value™ is $4.15, compared to a current price of $2.86 — trading 31.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $11.07. Aurora Cannabis' overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Aurora Cannabis (ACB), the current Cyclically Adjusted Revenue per Share is $11.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Cannabis (ACB) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued. The current stock price of $2.86 is trading 31.1% below its estimated GF Value™ of $4.15. GuruFocus considers Aurora Cannabis to be Possible Value Trap.

Key valuation signals for ACB:

  • Cyclically Adjusted Revenue per Share: $11.07
  • GF Value™: $4.15 vs. price of $2.86 (31.1% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aurora Cannabis Business Description

Address 90B Street SW, Suite 2207, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
59GF Score

Get the complete analysis for ACB

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.86
Price
$4.15
GF Value